What is Repaglinide (Prandin)?
Repaglinide is an oral hypoglycemic drug that belongs to a class of drugs called meglitinides. This oral medication lowers blood glucose in people with type 2 diabetes by stimulating the pancreas to produce insulin. Prandin can be used alone or in combination with other diabetes drugs such as metformin to control high blood sugar in people with type 2 diabetes. Repaglinide is usually given to type 2 diabetic patients after a program involving exercise, diet and weight loss was not successful in controlling their blood glucose levels.
What is Repaglinide used for?
Repaglinide is used to control blood sugar levels in people with type 2 diabetes. It should be used in conjunction with a good diet and plenty of exercise. Cardiovascular risk factors should be established before starting treatment with Repaglinide.
—
Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.
